Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$1.7 million.

  • Usana Health Sciences' Change in Account Payables fell 73233.08% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 62968.61%. This contributed to the annual value of -$1.3 million for FY2024, which is 19649.53% down from last year.
  • Per Usana Health Sciences' latest filing, its Change in Account Payables stood at -$1.7 million for Q3 2025, which was down 73233.08% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Change in Account Payables peaked at $3.8 million during Q2 2025, and registered a low of -$6.9 million during Q2 2021.
  • For the 5-year period, Usana Health Sciences' Change in Account Payables averaged around -$816000.0, with its median value being -$925000.0 (2023).
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 386494.25% in 2021, then skyrocketed by 214302.33% in 2023.
  • Over the past 5 years, Usana Health Sciences' Change in Account Payables (Quarter) stood at -$6.9 million in 2021, then surged by 101.25% to $86000.0 in 2022, then surged by 2143.02% to $1.9 million in 2023, then decreased by 7.98% to $1.8 million in 2024, then plummeted by 194.76% to -$1.7 million in 2025.
  • Its Change in Account Payables was -$1.7 million in Q3 2025, compared to $3.8 million in Q2 2025 and $2.0 million in Q1 2025.